Analysts are estimating that Elevance Health will report an earnings per share (EPS) of $4.96.
The market awaits Elevance Health's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Performance in Previous Earnings
The company's EPS missed by $0.35 in the last quarter, leading to a 8.38% drop in the share price on the following day.
Here's a look at Elevance Health's past performance and the resulting price change:
Quarter
Q2 2025
Q1 2025
Q4 2024
Q3 2024
EPS Estimate
9.19
11.38
3.86
9.66
EPS Actual
8.84
11.97
3.84
8.37
Price Change %
-8.00
3.00
0.00
-3.00
Tracking Elevance Health's Stock Performance
Shares of Elevance Health were trading at $348.77 as of October 17. Over the last 52-week period, shares are down 16.03%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
Analyst Insights on Elevance Health
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Elevance Health.
With 13 analyst ratings, Elevance Health has a consensus rating of Outperform. The average one-year price target is $371.77, indicating ...